BOSELLI, Maria Linda
 Distribuzione geografica
Continente #
NA - Nord America 2.676
EU - Europa 2.663
AS - Asia 1.579
SA - Sud America 179
AF - Africa 61
OC - Oceania 6
Totale 7.164
Nazione #
US - Stati Uniti d'America 2.621
RU - Federazione Russa 899
GB - Regno Unito 838
SG - Singapore 599
CN - Cina 475
IT - Italia 214
SE - Svezia 143
BR - Brasile 142
DE - Germania 141
VN - Vietnam 125
FI - Finlandia 116
HK - Hong Kong 109
FR - Francia 97
IE - Irlanda 89
KR - Corea 78
IN - India 46
CA - Canada 32
PK - Pakistan 28
JP - Giappone 22
BD - Bangladesh 21
UA - Ucraina 21
BE - Belgio 16
ID - Indonesia 16
PL - Polonia 16
ZA - Sudafrica 16
NL - Olanda 15
TR - Turchia 15
AT - Austria 14
MX - Messico 14
AR - Argentina 11
GR - Grecia 9
NG - Nigeria 9
UZ - Uzbekistan 8
DZ - Algeria 7
ES - Italia 7
GH - Ghana 7
IQ - Iraq 7
EG - Egitto 6
LT - Lituania 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
PY - Paraguay 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
CO - Colombia 4
ET - Etiopia 4
JO - Giordania 4
PH - Filippine 4
VE - Venezuela 4
CH - Svizzera 3
EC - Ecuador 3
SA - Arabia Saudita 3
TN - Tunisia 3
BG - Bulgaria 2
BJ - Benin 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GP - Guadalupe 1
JM - Giamaica 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 7.164
Città #
Southend 776
Ashburn 534
Dallas 364
Moscow 345
Singapore 285
Chandler 250
San Jose 187
Ann Arbor 125
Verona 120
Hong Kong 108
Beijing 105
Jacksonville 100
New York 95
Woodbridge 91
Dublin 89
Houston 81
Los Angeles 50
The Dalles 47
Helsinki 46
Munich 40
Ho Chi Minh City 38
Lawrence 32
Princeton 32
Wilmington 31
Seoul 30
Santa Clara 27
Jinan 26
Turku 25
Hanoi 23
Boardman 21
Frankfurt am Main 20
Nanjing 20
Shenyang 20
Redondo Beach 19
Tokyo 19
Redmond 18
Mianwali 17
Brussels 16
São Paulo 15
Buffalo 14
Tianjin 14
Warsaw 14
Orem 13
Montreal 12
Vienna 12
Changsha 11
Falkenstein 11
Hyderabad 11
Phoenix 11
Sindelfingen 11
Columbus 10
Hangzhou 10
Hebei 10
Johannesburg 10
Nuremberg 10
Stockholm 10
Washington 10
Amsterdam 9
Chennai 9
Dearborn 9
Dhaka 9
London 9
Romola 9
Shanghai 9
Chicago 8
Jakarta 8
Nanchang 8
Nikaia 8
Tashkent 8
Zhengzhou 8
Bologna 7
Boston 7
Dong Ket 7
Mumbai 7
San Francisco 7
Taiyuan 7
Accra 6
Brasília 6
Brooklyn 6
Da Nang 6
Haikou 6
Haiphong 6
Kent 6
Malda 6
Manchester 6
Taizhou 6
Abuja 5
Ankara 5
Cagliari 5
Charlotte 5
Council Bluffs 5
Denver 5
Milan 5
San José 5
Seattle 5
Toronto 5
Addis Ababa 4
Al Mansurah 4
Amman 4
Asunción 4
Totale 4.770
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 778
Common Variants Associated to Type 2 Diabetes in the Italian Population 491
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 243
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 225
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 222
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 218
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 213
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 209
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 203
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 199
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 199
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 191
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 190
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 189
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 185
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 179
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 178
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 177
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 173
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 170
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 166
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 156
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 154
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 153
“IGT-like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentration during the oral glucose tolerance test 152
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 151
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 150
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 144
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 141
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 140
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 127
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 122
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 121
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 119
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 115
Methods to assess in vivo insulin sensitivity and insulin secretion 110
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 104
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 104
Totale 7.261
Categoria #
all - tutte 20.522
article - articoli 11.470
book - libri 0
conference - conferenze 8.675
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 377
Totale 41.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 20 31 39
2021/2022318 52 73 18 44 13 9 4 14 9 6 14 62
2022/2023649 48 91 53 120 55 146 12 33 64 7 14 6
2023/2024781 14 24 39 48 50 132 11 281 6 73 75 28
2024/20251.069 36 65 47 219 45 53 70 31 166 46 112 179
2025/20262.841 174 175 324 486 795 191 240 147 147 162 0 0
Totale 7.261